Browse All

Current Filters

CLEAR FILTER x

TITLE

Late-onset Severe Neutropenia in a Patient with Relapsing Remitting Multiple Sclerosis Treated with Ocrelizumab

Safety Patterns over Time with Ozanimod During an Open-label Extension Trial in Patients with Relapsing Multiple Sclerosis